Clinical Trial Update: 26 Week Open Label Study Evaluating Single IA Injection of DUROLANE SJ for Treatment of Osteoarthritis Pain of the Ankle [Phase 4]

View source ↗

Summary

This document reports a 26-week open-label Phase 4 trial evaluating a single intra-articular injection of Durolane SJ for osteoarthritis pain in the ankle.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Ankle

Drugs mentioned

• DUROLANE SJ (sodium hyaluronate)

Snippet

Sponsor: Bioventus LLC | Conditions: Osteoarthritis | Phase 4 | Status: UNKNOWN